MDL Information Systems, Inc. to Acquire Afferent Systems, Inc.Business Editors/Medical Writers SAN LEANDRO San Leandro (săn lēăn`drō), city (1990 pop. 68,223), Alameda co., W Calif., on San Francisco Bay; inc. 1872. Metal, wood, and paper products; chemicals; leather goods; foods and beverages; medical equipment; lighting fixtures; and , Calif.--(BW HealthWire)--May 30, 2000 Acquisition to Facilitate Tighter Links Between MDL's Discovery Informatics Solutions and Afferent's Chemistry Workflow Products MDL MDL - (Originally "Muddle"). C. Reeve, Carl Hewitt and Gerald Sussman, Dynamic Modeling Group, MIT ca. 1971. Intended as a successor to Lisp, and a possible base for Planner-70. Basically LISP 1.5 with data types and arrays. Information Systems, Inc., the recognized leader in discovery informatics for the life science and chemical industries, announced today that it is acquiring Afferent afferent /af·fer·ent/ (af´er-ent) 1. conveying toward a center. 2. something that so conducts, such as a fiber or nerve. af·fer·ent adj. Systems, Inc., a leading provider of knowledge and experiment management tools for high-throughput discovery. The acquisition, effective June 2000, reflects MDL's continuing commitment to provide complete, scalable, and enterprise-wide informatics solutions for companies engaged in low-, medium-, and high-throughput discovery. Pat Rougeau, MDL's president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , said "We are delighted that Afferent and its products, which are extremely well-received in the marketplace, will become part of the MDL family. This acquisition is another component in MDL's strategy of key alliances and acquisitions to provide to our customers a full range of discovery informatics solutions covering the entire research discovery process." Many pharmaceutical, chemical, and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. already use combinations of MDL's discovery informatics solutions and Afferent's chemistry workflow products. The acquisition will facilitate tighter links between these two offerings, allowing companies to develop successful products more quickly and more cost-effectively. "MDL's mission is to continue to provide our customers with a robust discovery informatics framework," said Rudy Potenzone, MDL's senior vice president of marketing, product development, and strategic planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. . "The addition of Afferent's chemistry workflow solutions strengthens our ability to deliver state-of-the-art software, content, and services that comprise this framework. We are very pleased not only to acquire Afferent's impressive products and technology, but also its outstanding technical staff which supplements our expertise in high-throughput discovery solutions." "MDL and Afferent are a natural fit, with complementary skills and technology," said David Chapman, president of Afferent Systems. "Our current customers will continue to receive the same high-quality service and support, and will also benefit from this new synergy. We look forward to joining a company that provides the industry's most effective discovery informatics framework, which is essential to the ultimate success of high-throughput discovery." About Afferent Founded in 1996, Afferent Systems, Inc. is the leading provider of software solutions for combinatorial chemistry Combinatorial chemistry involves the rapid synthesis or the computer simulation of a large number of different but structurally related molecules. Introduction Synthesis of molecules in a combinatorial fashion can quickly lead to large numbers of molecules. . Its customers include both large multi-national pharmaceutical companies employing Afferent software on a corporate basis across several sites and smaller discovery companies. Afferent is located in San Francisco, California “San Francisco” redirects here. For other uses, see San Francisco (disambiguation). The City and County of San Francisco (EN IPA: [sænfrənˈsɪskoʊ] . About MDL MDL Information Systems ("MDL") is the recognized leader in discovery informatics for the life science and chemical industries. MDL software, content, and services provide the enterprise framework for identifying successful new products. MDL is an international business headquartered in San Leandro, CA with offices worldwide. MDL Information Systems, Inc. is a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Elsevier Science, Inc. MDL is a registered trademark in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. of MDL Information Systems, Inc. Afferent is a registered trademark of Afferent Systems, Inc. in the U.S. and other countries. All other product names or company names may be trademarks or registered trademarks of their respective holders. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion